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Abstract 
Aim of the study: Neonatal encephalopathy (NE) of hypoxic-ischaemic origin may cause death or life-
long disability which is reduced by therapeutic hypothermia (TH). Our objective was to assess HR 
response in infants undergoing TH after perinatal asphyxia.
Methods: We performed a retrospective case series, from a single-centre tertiary care NICU. We 
included ninety-two infants with NE of likely hypoxic-ischaemic origin, moderate or severe, treated 
with TH (n=60) or normothermia (n=32) who had 18 month outcome data and at least 12 HR 
recordings the first 24h after birth (1998–2010) Bristol, UK. Poor outcome was defined as death or 
severe disability. Data are reported as medians and 95% confidence intervals (CI).
Results: TH to 33.5 °C decreased HR by 30 bpm to 92 bpm (95% CI: 88,96) 12h after birth in infants 
with NE and good outcome as compared to infants treated at normothermia 118 bpm (95% CI: 
110,130). Despite constant low rectal temperature, HR increased gradually during cooling from 36 to 
72h to 97 bpm (89,106) approaching the normothermia group, 117 bpm (96,133). During TH, infants 
with poor outcome had higher HR at 12h after birth (112 bpm, 95%CI: 92,115) as compared to infants 
with good outcome (p=0.004). Inotropic support increased HR by 17 bpm in infants with good 
outcome and by 22 bpm in infants with poor outcome.
Conclusions: In NE, TH decreases HR the first day of life. HR remained lower during TH, but increased
during the last day of TH. Infants with poor outcome have higher HR. 
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INTRODUCTION
All neonates suffering from neonatal encephalopathy (NE) of assumed hypoxic-ischaemic 
origin are treated with therapeutic hypothermia (TH) within 6h after birth as standard of care to 
reduce mortality and improve neurological outcome. 1 Even after the introduction of TH, NE results in 
death or disability in 47% of infants with moderate or severe perinatal asphyxia. 2
Even a normal birth is a stressful event for the neonate, and immediately after birth heart 
rate (HR) is increased. In healthy neonates, HR stabilizes during the first day. The hypoxic-ischaemic 
insult that patients with perinatal asphyxia suffer from, has large impact on the cardiovascular 
system. In the present study we focused on HR.
Hypoxia per se reduce metabolism, reduce HR and decrease core temperature. 3 During TH, 
we reduce core temperature, with subsequent further reduction in HR. HR is decreased by 10 bpm in 
neonates when core temperature is reduced by 1°C in response to reduced metabolism. 4 Neonates 
undergoing TH has a rapid decrease in HR, but it has not been reported whether this reduction is 
maintained throughout prolonged cooling. Previous physiological reports indicate that when
unphysiological conditions are maintained, the human body has wide capacity of restoration of key 
variables. One example is the immediate reduction in cerebral blood flow seen during hypocapnia. 
During prolonged hypocapnia as well as hypercapnia in adults, cerebral blood flow is restored 
towards the baseline value and this is interpreted as a protective mechanism. 5
There are few reports on variability in HR response to the induction of TH. Here we report 
variability in HR response, and that this variability represents important clinical differences due to 
severity of the underlying hypoxic-ischaemic insult and inotropic support.
In this retrospective study we describe the normal reduction and restoration of HR during TH 
in NE infants. The optimal HR response to TH is illustrated by the infants with NE, who had good 
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outcome without inotropic support. We also describe the HR response in infants with and without
inotropic support in relation to outcome. Lastly, we discuss whether HR could be used as an early 
predictor of neurological outcome. 
The primary aim of this study was to determine the HR response during TH. 
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METHODS
Infants were included if they were recruited into a registered pilot study of TH, two 
randomized trials of TH/normothemia or were cooled when TH became standard treatment in Bristol 
and included in the TOBY register. 4, 6, 7, 8 All infants fulfilled the A, B and C entry criteria as defined for 
the CoolCap and TOBY trials: 6, 7 gestational age ≥ 36weeks and A: having reduced consciousness and 
at least one of; Apgar score ≤ 5 at 10 min, needing assisted ventilation by 10min, acidosis (pH < 7.0), 
or base deficit ≥16 mmol?L and B: moderate or severe clinical encephalopathy and C: moderately or 
severely abnormal aEEG or seizures. Patient records of the infants (1998–2010) Bristol, United 
Kingdom, were examined retrospectively to obtain cardiovascular variables and outcome and 
treatment (TH or normothermia). 9 All the above studies were approved by the local Research Ethics 
Committees including data collection after the trials (CH/2009/3091).
For both normothermia and TH infants, more than 90% of infants were ventilated during the 
first 3 days of life, and almost all of the infants had invasive blood pressure monitoring. Arterial blood 
gases were measured frequently according to clinical need. The infants were born between1998 and 
2010. Two modes of cooling were used. Selective head cooling (n = 4) (Olympic Medical Cool Care 
System, Olympic Medical, Seattle, WA, USA) with the rectal temperature maintained at 34.5 ± 0.5°C 
or whole body cooling (either a manually controlled cooling blanket (Tecotherm, TS Med 200M; 
Leister, UK (n=2)) or a servo-controlled cooling wrap (CritiCool, MTRE, Yavne, Israel (n=54)) was used 
with rectal temperature maintained at 33.5 ± 0.2°C. 10 The rectal temperature was stable during the 
TH.
Inotropic support was left to the clinicians’ decision guided by   a clinical treatment protocol 
starting inotropic support treating hypotension when mean arterial blood pressure <45 mmHg. The 
first drug of choice was dopamine with addition of dobutamine and norepinephrine as supplement. 
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In the records of 97 identified infants, 60 and 32 eligible infants with recorded outcome were 
treated with TH and normothermia respectively (missing outcome in 3 normothermia infants), and 
had at least 12 hourly HR electronic recordings for the first 24h (missing HR recordings in 1 TH and 1 
normothermia infant). Poor outcome was defined as death or severe disability using the Bayley 
Scales of Infant Development II, Mental Development Index (MDI) < 70 or Psychomotor Development 
Index (PDI) < 70, deafness or blindness. 7, 11 In infants without results from Bayley Scales of Infant 
Development II, the components of severe disability were used. 12 Severe disability was defined as 
any of the following: inability to walk, sit, use hands to feed, control head, speak, see or hear. 
Neurodevelopment was assessed by trained personnel not involved in the neonatal care or aware of 
treatment allocation. In 2 infants lost to follow up <18 months of age, a scoring system from MRI 
evidence of injury to the basal ganglia, thalami, internal capsule and white matter was used as a 
surrogate measure of poor outcome. 13
Statistical analysis
Demographic and clinical characteristics were summarized at baseline as counts and 
percentages of the total numbers of infants for categorical variables, and as medians and 
interquartile ranges for other continuous variables. Tables of 2 ? 2 were analysed with the ‘N-1’ X2
test. 14 Hodges–Lehmann’s estimates of 95% non-parametric confidence intervals (CI) of median 
were used to look for differences between groups. 15 P-values for comparisons of group data were 
found by two-tailed Mann–Whitney U-test. The area under the receiver operating curve (AUROC) 
was used for validity of HR as a predictor of neurological outcome. SPSS 20 (SPSS, Chicago, IL, USA), 
GraphPad Prism 6.0 for Windows (GraphPad Software, La Jolla California USA) and StatExact (Cytel 
Studio 7; Cytel Inc., Cambridge, MA, USA) were used for statistical calculations. The 95% CI of 
predictive values were calculated according to the efficient score method 
[http://faculty.vassar.edu/lowry/clin1.html]. 16 P < 0.05 was considered significant.
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RESULTS
Demographic and clinical variables
Table 1 shows the characteristics of the infants. The initial markers of severity before 6h of 
age were similar in the two treatment groups. The TH group received more inotropic support.
Effect of temperature on heart rate
The infants treated at normothermia started with HR at 139 bpm (95%CI: 119, 156) the first 
three hours after birth and showed a trend towards decreasing HR during the first days of life (figure 
1, red/grey line). At 24h after birth HR was 118 bpm (110-130), at 48h after birth 109 bpm (97-122) 
and at 72h after birth 117 bpm (96, 133). In the present normothermia cohort few hourly HR values 
were documented after 48h (7 infants with good outcome and reported HR).  
To investigate whether TH had an effect on the HR response, we compared normothermia 
and TH infants with NE with good outcome and without inotropic support. The TH infants started 
with HR at 131 bpm (123, 140) the first three hours after birth before TH was initiated. After 
initiation of TH (range 1-6h after birth), HR dropped rapidly to 89 bpm (85, 93) at 12h after birth in 
the infants with good outcome without inotropic support. TH reduced HR by 30 bpm between 12 and 
24h after birth compared to normothermia treated infants (p<0.0001, Wilcoxon matched-pairs 
signed rank test). HR stays low at 92 bpm until 36h after birth (86,98), HR then gradually increased to 
97 bpm (89,106) at 72h after birth (during last day of TH). HR increases with rewarming, and 
stabilizes at 111 bpm (101-122) when rewarmed (84h after birth).
Effect of inotropic drugs on heart rate
In the normothermia group, 31% of the infants received inotropic support, while 70% of the 
infants received inotropic support during TH (p=0.0004, table 1). Inotropic support increased the HR 
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at 12h after birth during TH (122 bpm vs 95 bpm, p=0.0002 Mann-Whitney test, figure 2). 
Normothermia infants received inotropic support from 8h (95%CI: 4, 12) after birth, while TH infants 
received inotropic support from 12h (95%CI: 9, 14).
During TH, relatively more infants with good outcome received inotropic support than 
normothermia infants with good outcome (p=0.001, n-1 X2). In the normothermia and TH groups 
with good outcome 1 of 13 and 25 of 40, respectively, received inotropic support. In the groups with 
poor outcome, 9 out of 19 normothermia treated infants and 17 of 20 TH infants received inotropic 
support. In normothermia, inotropic support was related to poor outcome (p=0.02, n-1 X2), while 
during TH inotropic support was not statistically related to poor outcome (p=0.08).
The mean arterial blood pressure during TH did not differ between the infants with and
without inotropic support (54 mmHg (n=9) vs 51 mmHg (n=29) at 12h after birth, respectively). Few
infants in each group had several observations of mean arterial blood pressure. 
Heart rate response to TH with good or poor outcome
The initial drop in HR differed according to inotropic support and outcome (figure 2). At the 
initiation of TH (<6h after birth), the HR drop in infants with good outcome and without inotropic 
support was rapid and substantial (~30 bpm). Poor outcome delayed the HR drop (no difference in 
time to start TH) and the decr ase was smaller. Inotropic support delayed and reduced the HR drop 
in infants with good outcome, while in infants with poor outcome and inotropic support, the HR drop 
was abolished. 
Nadir of the HR response after TH was reached at 12h after birth. Both during normothermia 
and TH, HR is higher in the groups with poor outcome than good outcome (p=0.005 and p<0.0001 
respectively, Mann-Whitney test, figure 3). HR at 12h during TH and normothermia had an AUROC of 
0.81 and 0.65 respectively on prediction of neurological outcome. 
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During TH, without inotropic support, the median HR at 12h was higher in infants with poor 
outcome compared to those with good outcome (112 bpm vs. 92 bpm, p=0.004 Mann-Whitney test, 
two-sided, table 2, figure 3). HR≤100 bpm significantly differentiated between good and poor 
outcome for TH infants without inotropic support (p = 0.001, ‘N-1’ X2 test). During TH without 
inotropic support, HR ≤100 bpm already at 12h, was predictive of good outcome in 27 out of 31. The 
accuracy of HR as a single early predictor for death or severe disability in the infants during TH was 
82% (95% CI: 65%, 92%) in infants without inotropic support.
Also during TH with inotropic support the median HR at 12h was higher in infants with poor 
outcome compared to those with good outcome (134 bpm vs. 109 bpm, p=0.02 Mann-Whitney test, 
two-sided, table 2).  However, the accuracy of HR as a single early predictor for death or severe 
disability in the infants during TH with inotropic support was lower, 68 % (95% CI: 45%, 85%).
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DISCUSSION
We found that HR decreases initially with 30 bpm during TH compared to during 
normothermia in NE infants. HR increased during TH and was higher at last day of hypothermia 
compared to the first day. Infants with poor outcome have higher HR the first day after birth 
compared to HR in infants with good outcome. Inotropic support reduces the HR drop during TH.
Normal HR response to therapeutic hypothermia in HIE infants
In healthy normothermic newborns, HR is 112 bpm on the first postnatal day and 118 bpm 
on the fifth postnatal day during quiet rest. 17 We found that normothermic NE infants have higher 
HR on the first postnatal day. TH elicits rapid cardiovascular changes. HR drops to 90 bpm at 12h 
after birth (6h after start of TH) in the infants with good outcome without inotropic support, followed 
by a gradual increase at the last day of TH. HR was restored after rewarming, to the level similar to 
normothermia treated HIE infants, and similar to the HR observed in healthy newborns. 17
We found that HR dropped 9 bpm per °C reduction in core temperature, similar to our 
previous findings in a small clinical study and in piglets. 4, 18 This drop in HR is a physiological response 
to the decreased metabolism during TH, and a reduction in HR during TH has been associated with 
improved neurological outcome after cardiac arrest in adults. 19
There is a debate whether TH is cardioprotective or cardiodepressive. Cardioprotective 
properties are suggested in the resuscitated neonatal heart. 20 On the other hand, reduced core 
temperature may stiffen the heart, making its relaxation, filling and contraction less efficient, with 
reduction in cardiac output in adults. 21 In infants the changes in cardiac output during TH are not 
clear. 22
Hypothermia treated infants receive more inotropic support than normothermia treated infants
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In our material, significantly more infants with good outcome received inotropic support 
during TH compared to during normothermia, but this material is not a randomized control trial. A 
large meta-analysis report that TH did not change the use of inotropic support, while a small study 
concluded that TH infants receives more inotropic support than during normothermia treatment. 23,24
The physiological decrease in HR during TH was counteracted by inotropic support in neonates, 
similar to previous findings in pigs. 25
The mean arterial blood pressure level for infants during TH did not differ between the 
infants with and without inotropic support, and it seems as clinicians aim for the same blood 
pressure at the two temperatures. 22 However, the optimal mean arterial blood pressure during TH is 
yet to be defined. 22
Could heart rate on the first postnatal day predict neurological outcome? 
Recently, lower heart rate (HR) during TH in adults after cardiac arrest was found to be 
associated with favourable outcome. 19 To the best of our knowledge, this has not been investigated 
in NE patients receiving TH. In our study, HR≤100 bpm at 12h after birth predicted good outcome in 
87% during TH without inotropic support. During TH, the accuracy of HR as a single early predictor for 
death or severe disability was 82% (95% CI: 65%, 92%) in infants without inotropic support. This is 
comparable to prediction from MRI findings at day 8. The accuracy of prediction of death or severe 
disability from MRI was 84% (95%CI: 74%, 94%). 13
HR is extremely easy to measure and independent on subjective scoring. In our current study, 
the predictability was lower during inotropic support and in view of the observation that 70% of the 
TH infants receive inotropic support which blunts the HR response during TH, makes HR a difficult 
predictor on neurological outcome. Other factors like pain or discomfort from being ventilated and 
cooled, sedation level and previous atropine boluses also influence HR. 26 We have previously found 
that premedication with atropine prior to intubation, increases HR lasting more than 8h after birth. 26
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HR is an important factor in stress scores of infants, and the clinician may be alert to the 
factors that may interfere with HR. As our study suggests, postnatal age will also influence HR.  
Limitations
Our retrospective study has several weaknesses. We evaluated the use of inotropic support 
as a dichotomous variable, while inotrope score with dose of medication, type of medication and 
number of medication, could improve the study. In addition, the time varying degree of base deficit 
may influence the HR response to TH. Other clinical information such as anti-convulsion medication, 
cardiac function and any severe infection should ideally have been included. A future prospective 
multi-centre study should include the bedside information listed above and assess cardiac function at 
different time points during TH and after rewarming. Until our current results are confirmed from a 
larger prospective study testing the suggested hypothesis, this knowledge should not be used in 
outcome prediction or counselling parents.
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CONCLUSIONS
Heart rate drops fast during therapeutic hypothermia in infants who do well.  The initial drop 
in heart rate is reduced and delayed in infants who receive inotropic support and develop poor 
outcome. Heart rate increases during the last day of therapeutic hypothermia and is restored when 
rewarmed. Heart rate ≤ 100 bpm at 12h after birth without inotropic support during therapeutic 
hypothermia is predictive of favourable neurological outcome. 
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Figure legends
Figure 1 Normal heart rate response after hypoxic-ischaemic encephalopathy in infants with good 
outcome
The two graphs represent the median heart rate response in infants treated for hypoxic-ischemic 
encephalopathy, grade II or III either at normothermia (red) or during 72h of therapeutic 
hypothermia (blue) started within 6 hours after birth. None of these infants received inotropic 
support. The shaded zones indicate the interquartile range between 25- and 75-percentiles. HR, 
Heart rate; TH, therapeutic hypothermia.
Figure 2 Median heart rate during therapeutic hypothermia divided by outcome and inotropic 
support
The four graphs represent the median heart rate response during therapeutic hypothermia for 
infants with poor outcome (grey) with (dotted line) and without inotropic support (solid line) and for 
infants with good outcome (black) with (dotted line) and without inotropic support (solid line). 
Infants with good outcome had lower median heart rate regardless of inotropic support. HR, Heart 
rate; TH, therapeutic hypothermia.
Figure 3 Heart rate at 12h after birth during normothermia and therapeutic hypothermia. 
Each symbol represents one infant’s heart rate at 12h after birth during therapeutic hypothermia or 
normothermia. The horizontal lines indicate median and interquartile range. Therapeutic 
hypothermia decreases heart rate. The infants with poor outcome had higher heart rate compared to 
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infants with good outcome, both during normothermia and therapeutic hypothermia. HR, Heart rate; 
TH, therapeutic hypothermia.
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Table 1 Patient characteristics in normothermia and therapeutic hypothermia infants
Normothermia 
(n=32)
Therapeutic 
Hypothermia 
(n=60)
P-value
Female 56% 48% >0.5
Gestational age 
(weeks)
40 
(38-41)
40 
(39-41)
0.67
Birth weight (g) 3428 
(3101-3798)
3240 
(3015-3665)
0.5
Apgar@10 min 6 
(4-8)
6 
(4-8)
0.87
Worst pH by ≤1hr 6.90 
(6.86-7.02)
6.90 
(6.83-7.09)
0.82
Inotropic support 
during NICU
31% 70% 0.0004
Seizures 56% 65% 0.4
Poor outcome 
(death or severe 
disability1)
59% 33% 0.02
Median and interquartile range. NICU, neonatal intensive care unit. P-values calculated by Mann-
Whitney or N-1 X2. Severe disability is described in methods.
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Table 2 Heart rate and neurological outcome during therapeutic hypothermia
HR at 12h after birth 
during therapeutic 
hypothermia
Without inotropic 
support
With inotropic support
Good outcome 92 bpm
(88, 96)
n=30
109
(85, 110)
n=10
Poor outcome 112 bpm
(92, 115)
n=8
134
(111, 145)
n=12
95% confidence interval calculated by Hodges-Lehmann’s estimate. 15
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